Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic predictor for EPO-increasing therapies. (2022)
Attributed to:
Using genetics to test the disease consequences of higher adiposity uncoupled from its adverse metabolic effects
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ajhg.2022.08.004
PubMed Identifier: 36055212
Publication URI: http://europepmc.org/abstract/MED/36055212
Type: Journal Article/Review
Volume: 109
Parent Publication: American journal of human genetics
Issue: 9
ISSN: 0002-9297